AHA to FDA Re: blood glucose monitoring test systems for prescription point of care use

AHA comments on the Food and Drug Administration's (FDA) draft guidance on blood glucose monitoring test systems (BGMS) for prescription point-of-care (POC) use.

Key Resources

Related Resources

Case Studies
HEN 2.0 Storyboards
Public
Case Studies
HEN 2.0 Case Studies
Public
Case Studies
Increase Penetration of Appropriate Palliative Care Consultation in a Health System
Public
Case Studies
Care Coordination - New Model
Public
Case Studies
Lean Six Sigma Reduces Troponin Turnaround Time by 94% for Cardiac Patients in Critical Access Hospital Emergency Department
Public
Case Studies
Physician Shadowing Impact on Doctor-Patient Communication
Public